Product Code: ETC6187218 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The oscillating positive expiratory pressure (OPEP) market in Australia is driven by the increasing prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis. OPEP devices help in clearing mucus from the lungs, improving breathing function, and reducing hospital visits. The Australia healthcare system is increasingly adopting these devices to enhance patient quality of life. However, market challenges include the high cost of OPEP devices and the need for more widespread patient education on their usage and benefits.
The oscillating positive expiratory pressure (OPEP) market in Australia is witnessing growth due to the increasing prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. OPEP devices are used to help clear mucus from the lungs, improving airflow and reducing symptoms of respiratory conditions. The trend towards home healthcare solutions is boosting the adoption of OPEP devices, as patients seek non-invasive ways to manage their respiratory health. Additionally, technological innovations in portable, easy-to-use OPEP devices are enhancing their popularity among patients and healthcare providers alike.
The OPEP market faces adoption challenges due to a lack of awareness among both patients and some healthcare providers. Devices are often underutilized due to patient noncompliance, especially among the elderly. Furthermore, reimbursement limitations and a lack of standardized guidelines for chronic respiratory disease management affect device penetration.
The oscillating positive expiratory pressure (OPEP) market in Australia offers growth potential in the healthcare and respiratory device sectors. OPEP devices are increasingly being used in the treatment of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions. As healthcare providers continue to focus on effective treatment options that enhance lung function and manage chronic respiratory diseases, there is a growing market for these devices. Investors can focus on companies that are innovating in portable, easy-to-use OPEP devices, as well as those investing in clinical studies that validate the efficacy of these devices in various respiratory conditions.
The government policies impacting the oscillating positive expiratory pressure (OPEP) market in Australia revolve around healthcare financing and respiratory health. Medicare and private insurance policies typically cover respiratory devices, including OPEP devices, for patients with chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Government initiatives that promote better healthcare for chronic diseases, including funding for respiratory therapy, influence the markets demand for OPEP devices. Regulatory oversight by the TGA ensures the safety and efficacy of medical devices, which contributes to consumer confidence and the growth of the OPEP market in Australia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market - Industry Life Cycle |
3.4 Australia Oscillating Positive Expiratory Pressure (OPEP) Market - Porter's Five Forces |
3.5 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Trends |
6 Australia Oscillating Positive Expiratory Pressure (OPEP) Market, By Types |
6.1 Australia Oscillating Positive Expiratory Pressure (OPEP) Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Facemask OPEP Devices, 2021- 2031F |
6.1.4 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Mouthpiece OPEP Devices, 2021- 2031F |
6.1.5 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Bottle OPEP Devices, 2021- 2031F |
6.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By COPD, 2021- 2031F |
6.2.3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Asthma, 2021- 2031F |
6.2.4 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Atelectasis, 2021- 2031F |
6.2.5 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Bronchitis, 2021- 2031F |
6.2.6 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Bronchiectasis, 2021- 2031F |
6.2.7 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenues & Volume, By Online Pharmacies/Online Sales, 2021- 2031F |
7 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Import-Export Trade Statistics |
7.1 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Export to Major Countries |
7.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Imports from Major Countries |
8 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Key Performance Indicators |
9 Australia Oscillating Positive Expiratory Pressure (OPEP) Market - Opportunity Assessment |
9.1 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Oscillating Positive Expiratory Pressure (OPEP) Market - Competitive Landscape |
10.1 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Revenue Share, By Companies, 2024 |
10.2 Australia Oscillating Positive Expiratory Pressure (OPEP) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |